• Gene splicing could improve pharma understanding of human genome
    Pharma developers' understanding of genomics could improve with better understanding of spliced genes in the transcription of the human genome


Gene splicing could improve pharma understanding of human genome

Jan 21 2011

A better awareness of how gene splicing increases the transcripts in the human genome beyond predicted levels could improve pharma researchers' understanding of the discipline of genomics in general.

Writing in genomics methodology and new research periodical Genome Biology, researchers from INRAN and the Sapienza Universita di Roma explain that many transcripts associated with alternatively spliced protein-coding genes cannot be linked directly with a specific functional protein.

This is in spite of the belief that spliced genes are the explanation for why the genomic sequence appears to be transcribed to an order of magnitude beyond that possible with predicted and characterised genes.

Mass spectrometry allowed alternative splicing human gene isoforms to be analysed for the plausibility of their predicted structure, the presence of uninterrupted functional domains and any active sites.

It is the latter point - and the conservation of those active sites - that offers the best opportunity for pharma researchers to correctly identify translated products, the team concludes.

Digital Edition

Chromatography Today - Buyers' Guide 2022

December 2021

In This Edition Modern & Practocal Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


Lab Asia 2023

Oct 10 2023 Hybrid event

MicroTAS 2023

Oct 15 2023 Katowice, Poland

ISPPP 2023

Nov 05 2023 Vienna, Austria

SETAC North America

Nov 12 2023 Louisville, KY, USA

Eastern Analytical Symposium

Nov 13 2023 Plainsboro, NJ, USA

View all events